A share price of Rocket Pharmaceuticals Inc [RCKT] is currently trading at $14.39, up 1.34%. An important factor to consider is whether the stock is rising or falling in short-term value. The RCKT shares have gain 12.51% over the last week, with a monthly amount drifted -15.20%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Goldman started tracking the stock with Neutral rating on April 02, 2024, and set its price target to $39. On October 24, 2023, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $65 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $45 on February 01, 2023. Canaccord Genuity initiated its recommendation with a Buy and recommended $53 as its price target on November 08, 2022. BTIG Research started tracking with a Buy rating for this stock on November 01, 2022, and assigned it a price target of $35. In a note dated July 08, 2022, Raymond James initiated an Outperform rating and provided a target price of $22 on this stock.
Rocket Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $12.62 and $32.53. Currently, Wall Street analysts expect the stock to reach $45.2 within the next 12 months. Rocket Pharmaceuticals Inc [NASDAQ: RCKT] shares were valued at $14.39 at the most recent close of the market. An investor can expect a potential return of 214.11% based on the average RCKT price forecast.
Analyzing the RCKT fundamentals
Gross Profit Margin for this corporation currently stands at 0.05% with Operating Profit Margin at -26.55%, Pretax Profit Margin comes in at -25.03%, and Net Profit Margin reading is -25.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.66, Equity is -0.63 and Total Capital is -0.77.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.18 points at the first support level, and at 13.98 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.56, and for the 2nd resistance point, it is at 14.74.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Rocket Pharmaceuticals Inc [NASDAQ:RCKT] is 6.05. On the other hand, the Quick Ratio is 6.05, and the Cash Ratio is 1.64.
Transactions by insiders
Recent insider trading involved Militello John, that happened on Nov 21 ’24 when 1224.0 shares were sold., Patel Kinnari completed a deal on Nov 21 ’24 to sell 4588.0 shares. Meanwhile, CEO Shah Gaurav sold 11091.0 shares on Nov 21 ’24.
